Evidence map›Paper›PMID 42459588›Full record

ArticleDusunen adam : Bakirkoy Ruh ve Sinir Hastaliklari Hastanesi yayin organi2025

Validation and psychometric evaluation of the Turkish version of the Reward Deficiency Syndrome Questionnaire (RDSQ-29).

Oguz Peker, Mustafa Ugurlu, Ali Gokhan Esim, Irem Peker, Gorkem Karakas Ugurlu, Ali Caykoylu, Ahmet Arif Ozyurt, Ibrahim Halil Akbas

Abstract read
In one paragraph

Article in Dusunen adam : Bakirkoy Ruh ve Sinir Hastaliklari Hastanesi yayin organi, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Oguz PekerAnkara Lokman Hekim Akay Hospital, Department of Psychiatry, Ankara, Turkiye.
Mustafa UgurluAnkara Yildirim Beyazit University Faculty of Medicine, Department of Psychiatry, Ankara, Turkiye.
Ali Gokhan EsimAlsancak Nevvar Salih Isgoren State Hospital, Department of Psychiatry, Turkiye.
Irem PekerAnkara Private Middle East Hospital, Department of Psychiatry, Ankara, Turkiye.
Gorkem Karakas UgurluAnkara Yildirim Beyazit University Faculty of Medicine, Department of Psychiatry, Ankara, Turkiye.
Ali CaykoyluAnkara Yildirim Beyazit University Faculty of Medicine, Department of Psychiatry, Ankara, Turkiye.
Ahmet Arif OzyurtBolu Izzet Baysal Mental Health and Diseases Hospital, Department of Psychiatry, Bolu, Turkiye.
Ibrahim Halil AkbasSanliurfa Training and Research Hospital, Department of Psychiatry, Sanliurfa, Turkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: This study aimed to assess the validity and reliability of the Turkish version of the Reward Deficiency Syndrome Questionnaire (RDSQ-29), a scale designed to measure characteristics associated with reward deficiency syndrome, including activity, risk-seeking behavior, lack of sexual dysfunction, and social concerns. Method: A total of 481 participants completed the Turkish version of the RDSQ-29 along with related psychological scales. Confirmatory Factor Analysis was conducted to evaluate the scale's factor structure. A bifactor model, comprising one general factor and four specific factors, was tested for suitability. Model fit was assessed using χ Results: The bifactor model demonstrated an acceptable fit (χ Conclusion: The findings indicate that the Turkish RDSQ-29 is a valid and reliable tool for assessing reward deficiency syndrome and related traits, supporting its use in both clinical and research contexts.

Indexed as

reliabilityReward Deficiency Syndrome Questionnaire-29Validity

Identifiers

PMID42459588
PMCPMC13289287

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.